We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.12 | 3.46% | 3.59 | 3.30 | 3.86 | 3.62 | 3.44 | 3.56 | 675,665 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pesticides, Agric Chems, Nec | 11.77M | -9.48M | -0.0278 | -1.30 | 12.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/4/2009 17:44 | Steg...I might have something for you if youd like to leave me your email address .. | nurdin | |
06/4/2009 15:50 | Hi steg...just completing my research on them. Initial feedback is that Monasto were originally planning to use harpin on soya bean fields covering about 5-6m acres.The new deal now is for supply to cover almost 7-8m acres which is a huge jump. PHC have to just sit back and collect royalties which I understand is about 4c per acre.On that basis PHC should record profits of almost $3.2m just for the current year. The potential going forward is enormous with Monasto planning application over 60m acres within 5 year and over 100m acres over 6yrs. Mouth watering !! I will keep digging :o) | nurdin | |
03/4/2009 17:51 | Nurdin, good to see you here. I bought back into these today on the back of the late (and i think missed) Monsanto RNS. Monsanto reported best ever results yesterday with outstanding numbers and growth. Didnt buy that many as i want to see how they raise finance first before committing more. If this goes correctly then its surely a bagger from here if the revenues start to flow..... | stegrego | |
03/4/2009 10:29 | If harpin is such a success and they have other technologies to coomercialise,the market will be more than happy to support imo | nurdin | |
03/4/2009 10:23 | "In the light of this development, as well as other technology commercialisation opportunities, the Board is reviewing all financing alternatives to meet the Company's investment and working capital needs, so as to ensure future sales growth potential is realised." No doubt it was sensible of them to trail this review of financing and put it in context so that there is no misinterpretation when they eventually make an announcement. | mdrans1 | |
03/4/2009 08:09 | John Brady, CEO of Plant Health Care commented, "This order underlines Monsanto's commitment to the rapid commercialisation of harpin. Plant Health Care's strategy of commercialising its patented technologies with the world's largest seed and agrichemical companies is now delivering for our shareholders and, for the first time in our history, our natural technologies will be applied by growers to millions of acres." I cant say I disagree...:o) | nurdin | |
03/4/2009 07:32 | ..and the chart is turning too :o) | nurdin | |
03/4/2009 07:29 | Anyone seen this? Sneaked in after hours last night.Could be transformational... | nurdin | |
04/2/2009 09:10 | Thanks AT useful article | topgallant | |
03/2/2009 11:41 | Tuesday, February 03, 2009 Plant Health Care: Substantial revenue growth on the horizonCare. Plant Health Care undeniably has products with immense potential, but to maximise the potential, it needs a big company - or companies - to adopt its technology. Full article ► | aim_trader | |
29/1/2009 12:32 | Plant Health Care appears as a buy in today's Shares mag chemicals sector report. | mdrans1 | |
06/1/2009 12:19 | Plant Health investors may be interested in meeting Plant Impact? The directors of Synchronica plc (AIM: SYNC), Plant Impact (AIM: PIM) and Medicsight (AIM: MDST) will be presenting: Thursday the 15th January 2009 Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, W1J 5EB. The presentations will start @ 6:00pm and finish at 7:30pm. After the presentations are complete the directors will also be available to take questions during a free canape and wine reception. Details on the presenting companies can be found at the above link. Plant Impact (AIM:PIM) Plant Impact specialises in plant stress relief. Plant Impact provide a dynamic and uncompromising new approach to crop nutrition and crop health, giving growers significantly increased marketable yields, more consistent quality with reduced environmental impact, leading to the ethically grown food demanded by consumers and the food chain. | ceohunter | |
18/12/2008 12:22 | duplicated | pugugly | |
18/12/2008 10:46 | surely Myconate was seen as the lead product (in terms of ultimate cash flow) so the Bayer cancellation is very worrying to me. It suggests that Mayconate may have "problems". Anyone much closer to the company/product area able to comment. | pugugly | |
18/12/2008 09:15 | seems an over-reaction - monsanto is the deal maker here - not bayer. | mdchand | |
18/12/2008 09:08 | Termination of Myconate Collaboration Agreement with Bayer CropScience "Plant Health Care is in agreement with this decision and believes this action is best for all parties." Code for we can get a better deal ? | mdrans1 | |
16/12/2008 15:54 | Medium term too. From the news header:- "Today's confirmation that Monsanto will deploy harpin in its seed-coating product for soybeans, corn, cotton and certain vegetables gives investors the long-term visibility they have been waiting for," says Philip Sparks at Evolution Securities. He estimates the deal could generate about 15 million pounds a year of earnings in the medium term, and the U.S. sales of harpin as a seed coating could be worth 450 pence per share on their own. | mdrans1 | |
16/12/2008 12:48 | Excellent news for long term revenue! | r0ss | |
19/6/2008 11:07 | We get half a page in this weeks Shares Mag. cover feature :- Food aid: The stock market solution Including this from the house broker ; "Philip Sparks at house broker Evolution Securities is bullish about the outlook for Plant Health Care, believing that 'the higher food prices go, the more cost-effective Plant Health Care's products become.' Plant Health Care also has the backing of Monsanto and Bayer, and Sparks believes that 'based on the Harpin roll-out projections from Monsanto and our Myconate forecasts for Bayer, Plant Health Care could conceivably deliver $40 million of annual earnings by 2012.' Sparks concludes that 'while 2007 was the year of validation for Plant Health Care, 2008 could be the year that soaring food prices boost the shares to record highs." Plus half a page under Agenda market news and analysis , thumbs up from Al Gore no less. :- Plant Health gets thumbs up Published date: Thursday, June 19, 2008 Gore fund underscores green agro-chemical company's excellent prospects by Timon Day A fund run by former vice president and environmental campaigner Al Gore increased its stake in Plant Health Care to 5.3% last week and could go substantially higher. Generation is an independent, private, owner managed partnership formed in 2004, based in London and co-founded by chairman Al Gore. Its new Climate Solutions Fund closed two months ago with $683 million to invest in small companies in four sectors: renewable energy, energy efficiency technologies, energy from biofuels and biomass, and the carbon trading markets. | mdrans1 | |
12/6/2008 10:40 | 12 June 2006 Plant Health Care plc ("Plant Health Care" or "the Company") OUTSTANDING YIELD GAINS IN WHEAT FOR MYCONATE * Results of field trials in Mexico * Significant sales of N-Hibit in South Africa Plant Health Care (AIM: PHC), a leading provider of natural products for plants and soil, is pleased to report the independent results of its second significant grower field trials of Myconate with wheat in Mexico. The results provide further compelling evidence of yield stimulation in this crop. These large scale trials conducted by local growers on areas varying from 3.4 to 6.25 hectares showed an average yield increase, over the control, of 20% with a range of 8% to 31% increases. The Myconate was seed applied using normal seed coating applications for Mexican agriculture. Importantly, the largest yield increases recorded were on fields that were treated with Myconate in the trials a year prior, providing evidence that the effect of Myconate is repeatable when used annually. John Brady, Chief Executive of Plant Health Care commented: "These results are again outstanding and provide further validation of the benefits of Myconate technology for cereal grains, taking us another step closer to commercialisation of the product". Plant Health Care also announces a further advance with the launch of its Harpin based N-Hibit product, which has been sold for grain application onto some 40,000 acres of cereal in South Africa. This opens a new front for the sale of Harpin which has traditionally been linked to the corn, soya bean and cotton markets. | lasata | |
09/6/2008 00:48 | some more encouraging announcements in last month successful product development and commercial relationships are the way to go | cnx | |
21/4/2008 11:02 | Drought hits millions in Thai rice region - government BANGKOK (Thomson Financial) - More than 10 million people in parts of Thailand's rice bowl region have been hit by drought, the government said Monday, causing further concerns as prices of the staple grain soar. Thailand's Disaster Prevention and Mitigation department reported that 55 of the kingdom's 76 provinces were struggling with drought, mostly in the central, north and northeastern regions. More than 151,000 rai (60,000 acres) of farmland has been affected, they said in a statement, including half of the key central rice growing provinces. Vichien Phantodee, a member of the Thai Farmers Association, said rice farmers have been trying to exploit skyrocketing prices and an increased global demand for the grain. "Farmers want to plant more rice because the price is so good," Vichien told Agence France-Presse. "But the drought does affect rice production, particularly for farmland outside the irrigation areas." The first rice harvest of the year in Thailand, the world's biggest rice exporter, traditionally ends in late March or early April. Farmers then let the fields recover, before planting a second harvest in May. But as export and domestic rice prices hit record highs, many farmers are trying to plant a third crop or move their second harvest forward to take advantage of the boom. The benchmark Thai variety, Pathumthani fragrant rice, was priced on April 9 at $956 per tonne for export, up about 50 percent from a month earlier, the Thai Rice Exporters Association said in its price survey. International demand for Thai rice has soared after other top exporters, Vietnam and India, imposed limits on exports to ensure domestic supply. | pre | |
21/4/2008 10:54 | Market cap of £150mm and loss making for the next few years doesn't strike me as excessively cheap. | wjccghcc | |
21/4/2008 07:03 | We could see a big rise with these over the next few days...look well cheap considering the rise in food prices imo... | pre | |
20/4/2008 20:32 | Tipped as a "buy" in Shares on 10th April 2008, same in IC on 18th April 2008 and again in the Sunday Telegraph today 20th April 2008. IC notes that the share price of Monsanto has "on average trebled in each of the last 5 years" although the chart shows a total gain in that period approaching 1400%. Bearing in mind that what appears to be the present world food crisis has only just begun plenty to go for here. | lunartik |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions